Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Rishi Wadhera, MD, MPP, MPhil, addresses performance metrics, cross-specialty prescribing, and the policy forces reshaping the cardiometabolic care cascade.

Q&A: CKM Care, IRA Policy, and Specialty Silos, With Rishi Wadhera, MD, MPP, MPhil

Panelists reached broad consensus that upfront dual oral combination therapy with an ERA and PDE5 inhibitor remains the foundational standard.

PAH Expert Forum: Sotatercept, De-escalation, and the Limits of Upfront Therapy

MOMENTUM data suggest hypercortisolism prevalence reached 43.6% among individuals with resistant hypertension and an eGFR below 45 mL/min/1.73 m².

MOMENTUM: Lower Kidney Function Could Signal Hypercortisolism in Resistant Hypertension

Diana Varghese, MD, discusses her recent study noting a 9% prevalence of PA among patients with incident hypertension and providing targets for further screening strategies.

Primary Aldosteronism More Common Than Previously Believed, Requires Increased Screening

Elena Christofides, MD, discusses the interim results of CAPTAIN-T2D, a trial that plans to evaluate clofutriben’s efficacy in these patients.

CAPTAIN-T2D: Interim Results Display High Cortisol Prevalence in Difficult-to-Control T2D

New data from ENDO 2026 have indicated a statistically significant increase in hypotension and related events in adults receiving GLP-1s who are already hypertensive.

GLP-1 Initiation Associated With Increase in Hypotensive Events in Patients With Hypertension

Stay updated with the latest healthcare breakthroughs, including FDA regulatory decisions, phase 3 data, and new clinical guidelines.

The HCPFive: Top News for Healthcare Providers from the Week of 05/31

Phase 3 post hoc data linked lorundrostat to lower systolic blood pressure and albuminuria in patients with hypertension and CKD.

Lorundrostat Lowers BP, Albuminuria in Phase 3 CKD Hypertension Analysis

Ferdinand shares his advice on high blood pressure management, drawing on his perspective as co-author of the ACC/AHA 2025 hypertension guidelines.

Paths Forward in Hypertension Awareness and Control, With Keith Ferdinand, MD

Stay updated with the latest healthcare breakthroughs, including FDA approvals and phase 3 data.

The HCPFive: Top News for Healthcare Providers from the Week of 05/17

The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.